What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Food

Nutraceutical Baby Food

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1525927

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1525927

Infant Clinical Nutrition Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

PUBLISHED: July 19, 2024

PAGES: 159 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for infant clinical nutrition. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Infant Clinical Nutrition Market Size (2024E): USD 27491.8 Mn
Projected Market Value (2033F): USD 45733.7 Mn
Global Market Growth Rate (CAGR 2024 to 2033): 5.8%

Infant Clinical Nutrition Market - Report Scope:

Infant clinical nutrition plays a critical role in supporting the health and development of newborns and infants globally. This market encompasses a wide range of nutritional products designed specifically for infants, including infant formula, baby food, and nutritional supplements. Key stakeholders in this market include manufacturers, healthcare providers, and regulatory bodies, each contributing to the market's growth and regulatory framework.

Market Growth Drivers:

The global infant clinical nutrition market is driven by several key factors, including increasing birth rates, rising awareness about the importance of early childhood nutrition, and advancements in nutritional science. The demand for specialized infant formulas catering to various health conditions such as lactose intolerance, allergies, and preterm birth complications fuels market expansion. Moreover, the growing adoption of organic and natural infant food products among health-conscious parents further stimulates market growth.

Market Restraints:

Despite promising growth prospects, the infant clinical nutrition market faces challenges related to stringent regulatory requirements, particularly concerning product safety, labeling, and advertising claims. Additionally, economic fluctuations, pricing pressures, and supply chain disruptions impact market dynamics, posing challenges for market players aiming for sustained profitability and market expansion.

Market Opportunities:

The infant clinical nutrition market presents significant growth opportunities driven by demographic trends, evolving dietary preferences, and advancements in nutritional research. Innovations in product formulations, such as hypoallergenic formulas and probiotic-enriched baby foods, cater to emerging consumer demands for healthier and functional infant nutrition options. Strategic collaborations between manufacturers, healthcare providers, and nutritionists are crucial in developing evidence-based nutritional solutions and expanding market reach across diverse demographic segments.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the infant clinical nutrition market globally?
Which product segments and nutritional formulations are witnessing increased adoption among parents and healthcare providers?
How are regulatory developments and consumer preferences shaping the competitive landscape of the infant clinical nutrition market?
Who are the key players contributing to the infant clinical nutrition market, and what strategies are they employing to maintain market leadership?
What are the emerging trends and future prospects in the global infant clinical nutrition market?

Competitive Intelligence and Business Strategy:

Leading players in the global infant clinical nutrition market, including Nestle S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Reckitt Benckiser Group plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce new nutritional products tailored to specific health needs and consumer preferences. Collaborations with pediatricians, hospitals, and retail channels enhance product distribution and market penetration, ensuring comprehensive infant nutrition solutions globally.

Key Companies Profiled:

Abbott Laboratories
Baxter International Inc.
Nestle S.A.
Danone
Meiji Holdings Co., Ltd.,
Fresenius SE & Co. KGaA
Reckitt Benckiser Group Plc
Perrigo Co. Plc
Ingredion Inc.
Solace Nutrition

Infant Clinical Nutrition Industry Research by Category

By Product Type:

Milk-Based
Soy-Based
Organic
Probiotic/Prebiotic

By Route of Administration:

Oral administration
Enteral administration
Intravenous administration

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa

Product Code: PMRREP22363

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market
- 3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
- 3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies

5. Global Infant Clinical Nutrition Market - Pricing Analysis

5.1. Regional Pricing Trend Analysis, 2019-2023
5.2. Global Average Pricing Analysis Benchmark

6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
- 6.2.1. Y-o-Y Growth Trend Analysis
- 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

7.1. Macro-Economic Factors
- 7.1.1. Global GDP Growth Outlook
- 7.1.2. Global Food & Beverage industry Overview
- 7.1.3. Global GDP and Infrastructure Investment
- 7.1.4. International Trade
- 7.1.5. Global Industry Outlook
7.2. Forecast Factors - Relevance & Impact
- 7.2.1. Top Companies Historical Growth
- 7.2.2. GDP Growth forecast
- 7.2.3. Manufacturing Industry forecast
- 7.2.4. Global Urbanization Growth Outlook
- 7.2.5. Business Climate
7.3. Global Food and Beverage Industry Overview
7.4. Global Dairy Industry Overview
7.5. Supply Chain & Value-Chain Analysis
- 7.5.1. Raw Material Suppliers
- 7.5.2. Product Manufacturers
- 7.5.3. Distribution Channel Industries
7.6. Policy Developments and Regulatory Scenario
- 7.6.1. The United States Food and Drug Administration (FDA)
- 7.6.2. Canadian Food Inspection Agency
- 7.6.3. European Food Safety Authority (EFSA)
- 7.6.4. The Food Safety and Standards Authority of India (FSSAI)
- 7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
- 7.6.6. National Health Commission (NHC), China
- 7.6.7. Food Standards Australia New Zealand (FSANZ)
7.7. Market Dynamics
- 7.7.1. Drivers
- 7.7.2. Restraints
- 7.7.3. Opportunity Analysis
7.8. Global Supply Demand Analysis

8. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2033
- 8.3.1. Milk-Based
- 8.3.2. Soy-Based
- 8.3.3. Organic
- 8.3.4. Probiotic/Prebiotic
8.4. Market Attractiveness Analysis By Product Type

9. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2019-2023
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2024-2033
- 9.3.1. Oral administration
- 9.3.2. Enteral administration
- 9.3.3. Intravenous administration
9.4. Market Attractiveness Analysis By Route of Administration

10. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia and Pacific
- 10.3.5. East Asia
- 10.3.6. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 11.4.1. By Country
  - 11.4.1.1. U.S.
  - 11.4.1.2. Canada
- 11.4.2. By Product Type
- 11.4.3. By Route of Administration
11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Product Type
- 11.5.3. By Route of Administration
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis

12. Latin America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 12.4.1. By Country
  - 12.4.1.1. Brazil
  - 12.4.1.2. Mexico
  - 12.4.1.3. Argentina
  - 12.4.1.4. Rest of Latin America
- 12.4.2. By Product Type
- 12.4.3. By Route of Administration
12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Product Type
- 12.5.3. By Route of Administration
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis

13. Europe Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 13.4.1. By Country
  - 13.4.1.1. Germany
  - 13.4.1.2. Italy
  - 13.4.1.3. France
  - 13.4.1.4. U.K.
  - 13.4.1.5. Spain
  - 13.4.1.6. BENELUX
  - 13.4.1.7. Russia
  - 13.4.1.8. Poland
  - 13.4.1.9. Rest of Europe
- 13.4.2. By Product Type
- 13.4.3. By Route of Administration
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Product Type
- 13.5.3. By Route of Administration
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis

14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 14.4.1. By Country
  - 14.4.1.1. India
  - 14.4.1.2. ASEAN
  - 14.4.1.3. Oceania (Australia & New Zealand)
  - 14.4.1.4. Rest of South Asia & Pacific
- 14.4.2. By Product Type
- 14.4.3. By Route of Administration
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Product Type
- 14.5.3. By Route of Administration
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis

15. East Asia Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 15.4.1. By Country
  - 15.4.1.1. China
  - 15.4.1.2. Japan
  - 15.4.1.3. South Korea
- 15.4.2. By Product Type
- 15.4.3. By Route of Administration
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product Type
- 15.5.3. By Route of Administration
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 16.4.1. By Country
  - 16.4.1.1. GCC Countries
  - 16.4.1.2. Turkey
  - 16.4.1.3. Northern Africa
  - 16.4.1.4. South Africa
  - 16.4.1.5. Rest of Middle East and Africa
- 16.4.2. By Product Type
- 16.4.3. By Route of Administration
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Product Type
- 16.5.3. By Route of Administration
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis

17. Country Wise Infant Clinical Nutrition Market Analysis, 2024

17.1. Introduction
- 17.1.1. Market Value Proportion Analysis, By Key Countries
- 17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Infant Clinical Nutrition Market Analysis
- 17.2.1. By Product Type
- 17.2.2. By Route of Administration
17.3. Canada Infant Clinical Nutrition Market Analysis
- 17.3.1. By Product Type
- 17.3.2. By Route of Administration
17.4. Mexico Infant Clinical Nutrition Market Analysis
- 17.4.1. By Product Type
- 17.4.2. By Route of Administration
17.5. Brazil Infant Clinical Nutrition Market Analysis
- 17.5.1. By Product Type
- 17.5.2. By Route of Administration
17.6. Argentina Infant Clinical Nutrition Market Analysis
- 17.6.1. By Product Type
- 17.6.2. By Route of Administration
17.7. Germany Infant Clinical Nutrition Market Analysis
- 17.7.1. By Product Type
- 17.7.2. By Route of Administration
17.8. Italy Infant Clinical Nutrition Market Analysis
- 17.8.1. By Product Type
- 17.8.2. By Route of Administration
17.9. France Infant Clinical Nutrition Market Analysis
- 17.9.1. By Product Type
- 17.9.2. By Route of Administration
17.10. U.K. Infant Clinical Nutrition Market Analysis
- 17.10.1. By Product Type
- 17.10.2. By Route of Administration
17.11. Spain Infant Clinical Nutrition Market Analysis
- 17.11.1. By Product Type
- 17.11.2. By Route of Administration
17.12. Poland Infant Clinical Nutrition Market Analysis
- 17.12.1. By Product Type
- 17.12.2. By Route of Administration
17.13. Russia Infant Clinical Nutrition Market Analysis
- 17.13.1. By Product Type
- 17.13.2. By Route of Administration
17.14. China Infant Clinical Nutrition Market Analysis
- 17.14.1. By Product Type
- 17.14.2. By Route of Administration
17.15. Japan Infant Clinical Nutrition Market Analysis
- 17.15.1. By Product Type
- 17.15.2. By Route of Administration
17.16. S. Korea Infant Clinical Nutrition Market Analysis
- 17.16.1. By Product Type
- 17.16.2. By Route of Administration
17.17. India Infant Clinical Nutrition Market Analysis
- 17.17.1. By Product Type
- 17.17.2. By Route of Administration
17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
- 17.18.1. By Product Type
- 17.18.2. By Route of Administration
17.19. Turkey Infant Clinical Nutrition Market Analysis
- 17.19.1. By Product Type
- 17.19.2. By Route of Administration
17.20. South Africa Infant Clinical Nutrition Market Analysis
- 17.20.1. By Product Type
- 17.20.2. By Route of Administration

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
- 19.3.1. Abbott Laboratories
  - 19.3.1.1. Overview
  - 19.3.1.2. Product Portfolio
  - 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.1.4. Sales Footprint
  - 19.3.1.5. Strategy Overview
- 19.3.2. Baxter International
  - 19.3.2.1. Overview
  - 19.3.2.2. Product Portfolio
  - 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.2.4. Sales Footprint
  - 19.3.2.5. Strategy Overview
- 19.3.3. Nestle S.A.
  - 19.3.3.1. Overview
  - 19.3.3.2. Product Portfolio
  - 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.3.4. Sales Footprint
  - 19.3.3.5. Strategy Overview
- 19.3.4. Danone
  - 19.3.4.1. Overview
  - 19.3.4.2. Product Portfolio
  - 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.4.4. Sales Footprint
  - 19.3.4.5. Strategy Overview
- 19.3.5. Meiji Holdings Co., Ltd.
  - 19.3.5.1. Overview
  - 19.3.5.2. Product Portfolio
  - 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.5.4. Sales Footprint
  - 19.3.5.5. Strategy Overview
- 19.3.6. Fresenius SE & Co. KGaA
  - 19.3.6.1. Overview
  - 19.3.6.2. Product Portfolio
  - 19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.6.4. Sales Footprint
  - 19.3.6.5. Strategy Overview
- 19.3.7. Reckitt Benckiser Group Plc
  - 19.3.7.1. Overview
  - 19.3.7.2. Product Portfolio
  - 19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.7.4. Sales Footprint
  - 19.3.7.5. Strategy Overview
- 19.3.8. Perrigo Co. Plc
  - 19.3.8.1. Overview
  - 19.3.8.2. Product Portfolio
  - 19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.8.4. Sales Footprint
  - 19.3.8.5. Strategy Overview
- 19.3.9. Ingredion Inc.
  - 19.3.9.1. Overview
  - 19.3.9.2. Product Portfolio
  - 19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.9.4. Sales Footprint
  - 19.3.9.5. Strategy Overview
- 19.3.10. Solace Nutrition
  - 19.3.10.1. Overview
  - 19.3.10.2. Product Portfolio
  - 19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.10.4. Sales Footprint
  - 19.3.10.5. Strategy Overview
- 19.3.11. Others ( on Additional Request)
  - 19.3.11.1. Overview
  - 19.3.11.2. Product Portfolio
  - 19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 19.3.11.4. Sales Footprint
  - 19.3.11.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ